BIVIWBiovie Inc.
Earnings
When Biovie Inc. reports, what it reported each quarter, and how the stock took the results.
47 quarters. Jun 30, 2013 to Sep 30, 2026. USD.
Next results · Q2 2027Projected
10-Q due Feb 3 – 16
No earnings release is on file for this company, so the day is the 10-Q’s, projected from its last 8 filings.
- Quarter
- Q2 2027 · Ends about Dec 31, 2026
- 10-Q window
- Feb 3 – 16
Read against Q2 2026
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- —
- Revenue, change from a year earlier: Q1 2016 n/m, Q1 2015 n/m
- Net income
- -$6.07M
- Net income, change from a year earlier: Q1 2027 n/m, Q4 2026 n/m, Q3 2026 n/m, Q2 2026 n/m
- EPS
- -$0.77
- EPS, change from a year earlier: Q1 2027 n/m, Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m
Latest results
- Q1 2027Nov 6, 2026, after the close
- Revenue
- —
- —
- Net income
- -$5.61M
- N/M
- EPS
- -$0.68
- N/M
- Revenue
- —
- —
- Net income
- -$5.65M
- N/M
- EPS
- —
- —
- Revenue
- —
- —
- Net income
- -$5.27M
- N/M
- EPS
- -$0.70
- N/M
- Revenue
- —
- —
- Net income
- -$6.07M
- N/M
- EPS
- -$0.77
- N/M
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2027 | ||||||||||
| Q1 2027 | Sep 30, 2026 | — | Nov 6, 2026 | 37 d | 10-Q | — | — | -$0.68 | — | |
| FY 2026 | ||||||||||
| Q4 2026derived | Jun 30, 2026 | — | Aug 13, 2026 | 44 d | 10-K | — | — | — | 8.7% | |
| Q3 2026 | Mar 31, 2026 | — | May 11, 2026 | 41 d | 10-Q | — | — | -$0.70 | 0.0% | |
| Q2 2026 | Dec 31, 2025 | — | Feb 6, 2026 | 37 d | 10-Q | — | — | -$0.77 | 0.0% | |
| Q1 2026 | Sep 30, 2025 | — | Nov 10, 2025 | 41 d | 10-Q | — | — | -$0.98 | — | |
| FY 2025 | ||||||||||
| Q4 2025derived | Jun 30, 2025 | — | Aug 15, 2025 | 46 d | 10-K | — | — | — | — | |
| Q3 2025 | Mar 31, 2025 | — | May 12, 2025 | 42 d | 10-Q | — | — | -$1.51 | — | |
| Q2 2025 | Dec 31, 2024 | — | Feb 11, 2025 | 42 d | 10-Q | — | — | -$4.55 | — | |
| Q1 2025 | Sep 30, 2024 | — | Nov 13, 2024 | 44 d | 10-Q | — | — | -$0.70 | — | |
| FY 2024 | ||||||||||
| Q4 2024derived | Jun 30, 2024 | — | Sep 30, 2024 | 92 d | 10-K | — | — | — | — | |
| Q3 2024 | Mar 31, 2024 | — | May 14, 2024 | 44 d | 10-Q | — | — | -$0.20 | — | |
| Q2 2024 | Dec 31, 2023 | — | Feb 13, 2024 | 44 d | 10-Q | — | — | -$0.22 | — | |
| Q1 2024 | Sep 30, 2023 | — | Nov 8, 2023 | 39 d | 10-Q | — | — | -$2.92 | — | |
| FY 2023 | ||||||||||
| Q4 2023derived | Jun 30, 2023 | — | Aug 16, 2023 | 47 d | 10-K | — | — | — | — | |
| Q3 2023 | Mar 31, 2023 | — | May 12, 2023 | 42 d | 10-Q | — | — | -$0.43 | — | |
| Q2 2023 | Dec 31, 2022 | — | Feb 10, 2023 | 41 d | 10-Q | — | — | -$0.50 | — | |
| Q1 2023 | Sep 30, 2022 | — | Nov 4, 2022 | 35 d | 10-Q | — | — | -$0.38 | — | |
| FY 2022 | ||||||||||
| Q4 2022derived | Jun 30, 2022 | — | Sep 27, 2022 | 89 d | 10-K | — | — | — | — | |
| Q3 2022 | Mar 31, 2022 | — | May 11, 2022 | 41 d | 10-Q | — | — | -$0.28 | — | |
| Q2 2022 | Dec 31, 2021 | — | Feb 8, 2022 | 39 d | 10-Q | — | — | -$0.22 | — | |
| Q1 2022 | Sep 30, 2021 | — | Nov 10, 2021 | 41 d | 10-Q | — | — | -$0.23 | — | |
| FY 2021 | ||||||||||
| Q4 2021derived | Jun 30, 2021 | — | Aug 30, 2021 | 61 d | 10-K | — | — | — | — | |
| Q3 2021 | Mar 31, 2021 | — | May 10, 2021 | 40 d | 10-Q | — | — | -$0.22 | — | |
| Q2 2021 | Dec 31, 2020 | — | Jan 29, 2021 | 29 d | 10-Q | — | — | -$0.22 | — | |
| Q1 2021 | Sep 30, 2020 | — | Nov 5, 2020 | 36 d | 10-Q | — | — | -$7.75 | — | |
| FY 2020 | ||||||||||
| Q4 2020derived | Jun 30, 2020 | — | Aug 6, 2020 | 37 d | 10-K | — | — | — | — | |
| Q3 2020 | Mar 31, 2020 | — | May 13, 2020 | 43 d | 10-Q | — | — | -$0.07 | — | |
| Q2 2020 | Dec 31, 2019 | — | Feb 13, 2020 | 44 d | 10-Q | — | — | $1.29 | — | |
| Q1 2020 | Sep 30, 2019 | — | Nov 19, 2019 | 50 d | 10-Q | — | — | -$5.06 | — | |
| FY 2017 | ||||||||||
| Q1 2017 | Sep 30, 2017 | — | Nov 8, 2017 | 39 d | 10-Q | — | — | -$0.01 | — | |
| FY 2016 | ||||||||||
| Q4 2016derived | Jun 30, 2017 | — | Aug 24, 2017 | 55 d | 10-K | — | — | — | — | |
| Q3 2016 | Mar 31, 2017 | — | May 9, 2017 | 39 d | 10-Q | — | — | $0.00 | — | |
| Q2 2016 | Dec 31, 2016 | — | Feb 7, 2017 | 38 d | 10-Q | — | — | $0.00 | — | |
| Q1 2016 | Sep 30, 2016 | — | Nov 16, 2016 | 47 d | 10-Q | $0.00 | — | $0.00 | — | |
| FY 2015 | ||||||||||
| Q4 2015derived | Jun 30, 2016 | — | Sep 28, 2016 | 90 d | 10-K | — | — | — | — | |
| Q3 2015 | Mar 31, 2016 | — | May 23, 2016 | 53 d | 10-Q | — | — | $0.00 | — | |
| Q2 2015 | Dec 31, 2015 | — | Feb 16, 2016 | 47 d | 10-Q | — | — | $0.00 | — | |
| Q1 2015 | Sep 30, 2015 | — | Nov 13, 2015 | 44 d | 10-Q | $0.00 | — | $0.00 | — | |
| FY 2014 | ||||||||||
| Q4 2014derived | Jun 30, 2015 | — | Oct 1, 2015 | 93 d | 10-K | — | — | — | — | |
| Q3 2014 | Mar 31, 2015 | — | May 11, 2015 | 41 d | 10-Q | — | — | $0.00 | — | |
| Q2 2014 | Dec 31, 2014 | — | Feb 5, 2015 | 36 d | 10-Q | — | — | $0.00 | — | |
| Q1 2014 | Sep 30, 2014 | — | Nov 13, 2014 | 44 d | 10-Q | — | — | $0.00 | — | |
| FY 2013 | ||||||||||
| Q4 2013derived | Jun 30, 2014 | — | Sep 24, 2014 | 86 d | 10-K | — | — | — | — | |
| Q3 2013 | Mar 31, 2014 | — | May 9, 2014 | 39 d | 10-Q | — | — | $0.00 | — | |
| Q2 2013 | Dec 31, 2013 | — | Jan 29, 2014 | 29 d | 10-Q | — | — | $0.00 | — | |
| Q1 2013 | Sep 30, 2013 | — | Nov 13, 2013 | 44 d | 10-Q | — | — | $0.00 | — | |
| FY 2012 | ||||||||||
| Q4 2012 | Jun 30, 2013 | — | — | — | — | — | — | — | — | |
Earlier years, FY 2012 to FY 2024The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
Biovie Inc. · CIK 1580149 · Engraved from SEC EDGAR